Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR™ T Cells in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

NCT04044768 is registered in ClinicalTrials.gov with USWM CT, LLC as lead sponsor.

NCT NCT04044768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04044768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR™ T Cells in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Lead sponsor
USWM CT, LLC
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 13, 2019
Completion date
April 1, 2038
Enrollment
52 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

myxoid liposarcoma, synovial sarcoma